{"id":"W4402933950","doi":"10.3389/fonc.2024.1417484","title":"BRAF/MEK inhibitors use for pediatric gliomas; real world experience from a resource-limited country","year":2024,"lang":"en","type":"article","venue":"Frontiers in Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; CDKN2A; Neurofibromatosis; Trametinib; MEK inhibitor; Dabrafenib; Oncology; Melanoma; Pleomorphic xanthoastrocytoma; Internal medicine; PDGFRA; Biopsy; Glioma; Gastroenterology; Cancer; Cancer research; MAPK/ERK pathway; Radiology; Astrocytoma; Vemurafenib; GiST; Kinase; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001556595,0.0002362587,0.0005550118,0.0008677025,0.0000654141,0.0000561273,0.0001163097,0.0002438705,0.00006486759],"category_scores_gemma":[0.0001802911,0.0002068152,0.000143146,0.001074659,0.0001173334,0.0001354835,0.00005688057,0.0002441238,0.00001293681],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000892762,"about_ca_system_score_gemma":0.0002638905,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005584764,"about_ca_topic_score_gemma":0.0005182822,"domain_scores_codex":[0.9982049,0.00007840766,0.0004469802,0.0005951923,0.0002166221,0.0004578255],"domain_scores_gemma":[0.9987185,0.0006647636,0.00007936329,0.0003033426,0.00004613418,0.0001879201],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0006891937,0.0006574053,0.5931676,0.00007087942,0.0001595398,0.002037422,0.002057535,0.00001130403,0.0002625478,0.0002452542,0.3822726,0.01836869],"study_design_scores_gemma":[0.004621333,0.001035587,0.09987807,0.0001864281,0.0005567612,0.00003373116,0.001872253,0.002017753,0.001268334,0.0005842426,0.8875875,0.0003580184],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9878811,0.004819949,0.0002570977,0.001435803,0.003314954,0.0008916939,0.0001824181,0.0001605092,0.001056454],"genre_scores_gemma":[0.9818576,0.0008749426,0.0130966,0.0008295056,0.001466906,0.0008782321,0.0003875963,0.00007442955,0.0005342122],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5053149,"threshold_uncertainty_score":0.8433681,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02209467647078669,"score_gpt":0.309910914580263,"score_spread":0.2878162381094764,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}